)
)
Cyxone Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Cyxone
Access all reports
Cyxone is a Swedish biotechnology company focused on developing innovative treatments for autoimmune and immune-related diseases. The company's research and development efforts center on creating therapies that modulate the immune system to treat conditions such as rheumatoid arthritis and multiple sclerosis. The company is headquartered in Malmö, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
)
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
)
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
CYXO
Country
🇸🇪 Sweden